BICARD 5 bisoprolol fumarate 5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

bicard 5 bisoprolol fumarate 5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - bisoprolol fumarate, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; lactose monohydrate; crospovidone; magnesium stearate; iron oxide yellow - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors and diuretics and, optionally, cardiac glycosides.

BISOPROLOL FUMARATE INOVAMED 5 MG Israel - English - Ministry of Health

bisoprolol fumarate inovamed 5 mg

inovamed ltd - bisoprolol fumarate - film coated tablets - bisoprolol fumarate 5 mg - bisoprolol - - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.- hypertension. - coronary heart disease (angina pectoris).

BISOPROLOL FUMARATE INOVAMED 5 MG Israel - English - Ministry of Health

bisoprolol fumarate inovamed 5 mg

inovamed ltd - bisoprolol fumarate - film coated tablets - bisoprolol fumarate 5 mg - bisoprolol - - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.- hypertension. - coronary heart disease (angina pectoris).

Co-Bisoprolol Viatris   5 mg - 12.5 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

co-bisoprolol viatris 5 mg - 12.5 mg film-coat. tabl.

viatris gx bv-srl - bisoprolol fumarate 5 mg; hydrochlorothiazide 12,5 mg - film-coated tablet - 5 mg - 12,5 mg - bisoprolol fumarate 5 mg; hydrochlorothiazide 12.5 mg - bisoprolol and thiazides

Bisoprolol 5mg New Zealand - English - Medsafe (Medicines Safety Authority)

bisoprolol 5mg

max health limited - bisoprolol fumarate 5mg;   - film coated tablet - 5 mg - active: bisoprolol fumarate 5mg   excipient: colloidal silicon dioxide hypromellose macrogol 400 magnesium stearate microcrystalline cellulose povidone purified talc purified water sodium starch glycolate titanium dioxide - indicated for: -treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ace inhibitors and diuretics, and optionally cardiac glycosides. -treatment of chronic, stable angina pectoris. -treatment of essential hypertension.

BISOPROLOL FUMARATE TABLET Canada - English - Health Canada

bisoprolol fumarate tablet

sanis health inc - bisoprolol fumarate - tablet - 5mg - bisoprolol fumarate 5mg - beta-adrenergic blocking agents

BISOPROLOL FUMARATE INOVAMED 10 MG Israel - English - Ministry of Health

bisoprolol fumarate inovamed 10 mg

inovamed ltd - bisoprolol fumarate - film coated tablets - bisoprolol fumarate 10 mg - bisoprolol - - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.- hypertension. - coronary heart disease (angina pectoris).

BISOPROLOL FUMARATE INOVAMED 10 MG Israel - English - Ministry of Health

bisoprolol fumarate inovamed 10 mg

inovamed ltd - bisoprolol fumarate - film coated tablets - bisoprolol fumarate 10 mg - bisoprolol - - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.- hypertension. - coronary heart disease (angina pectoris).

BISOPROLOL FUMARATE INOVAMED 2.5 MG Israel - English - Ministry of Health

bisoprolol fumarate inovamed 2.5 mg

inovamed ltd - bisoprolol fumarate - film coated tablets - bisoprolol fumarate 2.5 mg - bisoprolol - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.